Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability

Journal of Cellular Biochemistry

Volumn 113, Issue 4, 2012, Pages 1159-1169

  Munjal, Charu ^a   Tyagi, Neetu ^a   Lominadze, David ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

INFLAMMATORY BOWEL DISEASE; MICROVASCULAR REMODELING; PARACELLULAR TRANSPORT; TRANSCELLULAR TRANSPORT

Indexed keywords

BOVINE SERUM ALBUMIN; CADHERIN; CAVEOLIN 1; CELL PROTEIN; CHOLERA TOXIN; F ACTIN; FLUORESCEIN ISOTHIOCYANATE; GELATINASE B; HOMOCYSTEINE; MATRIX METALLOPROTEINASE INHIBITOR; OCCLUDIN;

ARTICLE; CAVEOLA; CELL INTERACTION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; IMPEDANCE; MICROVASCULAR ENDOTHELIAL CELL; PARACELLULAR PERMEABILITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TIGHT JUNCTION; TRANSCELLULAR PERMEABILITY;

BOVINAE;

EID: 84857519067     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23451     Document Type: Article

References (53)

1. Barr TL, Latour LL, Lee KY, Schaewe TJ, Luby M, Chang GS, El-Zammar Z, Alam S, Hallenbeck JM, Kidwell CS, Warach S,. 2010. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 41 (3): e123-e128.
2. Boardman KC, Aryal AM, Miller WM, Waters CM,. 2004. Actin re-distribution in response to hydrogen peroxide in airway epithelial cells. J Cell Physiol 199 (1): 57-66.
3. Bonoiu A, Mahajan SD, Ye L, Kumar R, Ding H, Yong KT, Roy I, Aalinkeel R, Nair B, Reynolds JL, Sykes DE, Imperiale MA, Bergey EJ, Schwartz SA, Prasad PN,. 2009. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res 1282: 142-155.
4. Castaneda FE, Walia B, Vijay-Kumar M, Patel NR, Roser S, Kolachala VL, Rojas M, Wang L, Oprea G, Garg P, Gewirtz AT, Roman J, Merlin D, Sitaraman SV,. 2005. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: Central role of epithelial-derived MMP. Gastroenterology 129 (6): 1991-2008.
5. Chidlow JH, Jr., Greer JJ, Anthoni C, Bernatchez P, Fernandez-Hernando C, Bruce M, Abdelbaqi M, Shukla D, Granger DN, Sessa WC, Kevil CG,. 2009. Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis. Gastroenterology 136 (2): 575-584.
6. Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, Adley BP, Stack MS, Hudson LG,. 2008. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 68 (12): 4606-4613.
7. Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS,. 2011. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 17 (5): 578-593.
8. Dong GH, Wang CT, Li Y, Xu B, Qian JJ, Wu HW, Jing H,. 2009. Cardiopulmonary bypass induced microcirculatory injury of the small bowel in rats. World J Gastroenterol 15 (25): 3166-3172.
9. Ebbing M, Bleie Ã, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Ringdal Pedersen EK, NygÃ¥rd O,. 2008. Mortality and cardiovascular events in patients treated with homocysteine-lowering b vitamins after coronary angiography. JAMA 300 (7): 795-804.
10. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM,. 1998. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273 (45): 29745-29753.
11. Feron O, Saldana F, Michel JB, Michel T,. 1998. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem 273 (6): 3125-3128.
12. Fulton D, Gratton JP, Sessa WC,. 2001. Post-translational control of endothelial nitric oxide synthase: Why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 299 (3): 818-824.
13. Gao J, Xue A,. 2003. Study on the oxidative injury of ECV304 cell induced by homocysteine. Wei Sheng Yan Jiu 32 (1): 20-21.
14. Garg P, Vijay-Kumar M, Wang L, Gewirtz AT, Merlin D, Sitaraman SV,. 2009. Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis. Am J Physiol Gastrointest Liver Physiol 296 (2): G175-G184.
15. Giaever I, Keese CR,. 1986. Use of electric fields to monitor the dynamical aspect of cell behavior in tissue culture. IEEE Trans Biomed Eng 33 (2): 242-247.
16. Givvimani S, Munjal C, Gargoum R, Sen U, Tyagi N, Vacek JC, Tyagi SC,. 2011. Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol 110 (4): 1093-1100.
17. Hatoum OA, Binion DG, Otterson MF, Gutterman DD,. 2003. Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation. Gastroenterology 125 (1): 58-69.
18. Ji C, Kaplowitz N,. 2004. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol 10 (12): 1699-1708.
19. Kamoun WS, Karaa A, Kresge N, Merkel SM, Korneszczuk K, Clemens MG,. 2006. LPS inhibits endothelin-1-induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin-1. Hepatology 43 (1): 182-190.
20. Lisanti MP, Tang ZL, Sargiacomo M,. 1993. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae. J Cell Biol 123 (3): 595-604.
21. Lischper M, Beuck S, Thanabalasundaram G, Pieper C, Galla HJ,. 2010. Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions. Brain Res 1326: 114-127.
22. Liu W, Hendren J, Qin XJ, Shen J, Liu KJ,. 2009. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J Neurochem 108 (3): 811-820.
23. Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC,. 2006. Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol 290 (3): H1206-H1213.
24. Mahmood A, Needham J, Prosser J, Mainwaring J, Trebble T, Mahy G, Ramage J,. 2005. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 17 (7): 739-744.
25. Majno G, Palade GE,. 1961. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: An electron microscopic study. J Biophys Biochem Cytol 11: 571-605.
26. Malik AB, Lynch JJ, Cooper JA,. 1989. Endothelial barrier function. J Invest Dermatol 93 (2 Suppl): 62S-67S.
27. Mehta D, Malik AB,. 2006. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86 (1): 279-367.
28. Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB,. 2003. Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285 (6): L1179-L1183.
29. Mook ORF, Overbeek CV, Ackema EG, Maldegem FV, Frederiks WM,. 2003. In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin. J Histochem Cytochem 51 (6): 821-829.
30. Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson B, Tyagi N, Zhang H, Tyagi SC,. 2006. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 291 (6): H2825-H2835.
31. Munjal C, Givvimani S, Qipshidze N, Tyagi N, Falcone JC, Tyagi SC,. 2011. Mesenteric vascular remodeling in hyperhomocysteinemia. Mol Cell Biochem 348 (1-2): 99-108.
32. Patibandla PK, Tyagi N, Dean WL, Tyagi SC, Roberts AM, Lominadze D,. 2009. Fibrinogen induces alterations of endothelial cell tight junction proteins. J Cell Physiol 221 (1): 195-203.
33. Persson CC,. 1986. The role of microvascular permeability in the pathogenesis of asthma. Eur J Respir Dis Suppl 144: 190-216.
34. Phillips PG, Birnby LM,. 2004. Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface. Am J Physiol Lung Cell Mol Physiol 286 (5): L1055-L1065.
35. Rosell A, Ortega-Aznar A, Alvarez-Sabín J, Fernández- Cadenas I, Ribõ M, Molina CA, Lo EH, Montaner J,. 2006. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37 (6): 1399-1406.
36. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG,. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68 (4): 673-682.
37. Silva W, Maldonado H, Chompre G, Mayol N,. 1998. Caveolae a new subcellular transport organelle. Bol Asoc Med PR 90 (1-3): 30-33.
38. Singh RD, Puri V, Valiyaveettil JT, Marks DL, Bittman R, Pagano RE,. 2003. Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol Biol Cell 14 (8): 3254-3265.
39. Smith U, Ryan JW, Smith DS,. 1973. Freeze-etch studies of the plasma membrane of pulmonary endothelial cells. J Cell Biol 56 (2): 492-499.
40. Starkebaum G, Harlan JM,. 1986. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77 (4): 1370-1376.
41. Stocco G, Martelossi S, Sartor F, Toffoli G, Lionetti P, Barabino A, Fontana M, Decorti G, Bartoli F, Giraldi T, Ventura A,. 2006. Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. Dig Dis Sci 51 (3): 474-479.
42. Sun Y, Hu G, Zhang X, Minshall RD,. 2009. Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways. Circ Res 105 (7): 676-685, 615.
43. Szepes Z, Kiss J, Molnar T, Lamarque D, Jancso G, Laszlo F,. 1997. Capsaicin-sensitive mechanisms in the modulation of rat colonic vascular permeability under physiological and pathological conditions. J Physiol Paris 91 (3-5): 123-126.
44. Tada Y, Yagi K, Kitazato KT, Tamura T, Kinouchi T, Shimada K, Matsushita N, Nakajima N, Satomi J, Kageji T, Nagahiro S,. 2010. Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats. J Hypertens 28 (9): 1883-1891.
45. Tiruppathi C, Shimizu J, Miyawaki-Shimizu K, Vogel SM, Bair AM, Minshall RD, Predescu D, Malik AB,. 2008. Role of NF-kappaB-dependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide. J Biol Chem 283 (7): 4210-4218.
46. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME,. 1994. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91 (14): 6369-6373.
47. Tyagi N, Moshal KS, Tyagi SC, Lominadze D,. 2007. gamma-Aminbuturic acid A receptor mitigates homocysteine-induced endothelial cell permeability. Endothelium 14 (6): 315-323.
48. Tyagi N, Roberts AM, Dean WL, Tyagi SC, Lominadze D,. 2008. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem 307 (1-2): 13-22.
49. Tyagi SC, Smiley LM, Mujumdar VS,. 1998. Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone. Mol Cell Biochem 181 (1): 107-116.
50. Van Driessche W, Kreindler JL, Malik AB, Margulies S, Lewis SA, Kim KJ,. 2007. Interrelations/cross talk between transcellular transport function and paracellular tight junctional properties in lung epithelial and endothelial barriers. Am J Physiol Lung Cell Mol Physiol 293 (3): L520-L524.
51. Vasile E, Simionescu M, Simionescu N,. 1983. Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J Cell Biol 96 (6): 1677-1689.
52. Wallez Y, Huber P,. 2008. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778 (3): 794-809.
53. Wilcken DE, Wilcken B,. 1976. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 57 (4): 1079-1082.